Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro
- PMID: 284362
- PMCID: PMC382963
- DOI: 10.1073/pnas.76.1.473
Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro
Abstract
Several carriers were evaluated for use in the delivery of exogenous glucocerebrosidase to monocytes from Gaucher's disease patients. Only gamma globulin-coated, resealed erythrocytes proved to be an effective vehicle for enzyme delivery. Glucocerebrosidase added in this manner normalized intracellular enzyme levels for at least 18 hr. In this model system for the study of enzyme replacement therapy, soluble enzyme, enzyme in uncoated resealed erythrocytes, and enzyme incorporated into liposomes were ineffective.
Similar articles
-
Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.Proc Natl Acad Sci U S A. 1976 Dec;73(12):4672-4. doi: 10.1073/pnas.73.12.4672. Proc Natl Acad Sci U S A. 1976. PMID: 1070017 Free PMC article.
-
Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase.Lancet. 1977 Jul 16;2(8029):116-7. doi: 10.1016/s0140-6736(77)90123-4. Lancet. 1977. PMID: 69198
-
Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry.J Neurol. 1987 Jan;234(1):44-51. doi: 10.1007/BF00314009. J Neurol. 1987. PMID: 3819786
-
Imiglucerase and its use for the treatment of Gaucher's disease.Expert Opin Pharmacother. 2008 Aug;9(11):1987-2000. doi: 10.1517/14656566.9.11.1987. Expert Opin Pharmacother. 2008. PMID: 18627336 Review.
-
Mammalian glucocerebrosidase: implications for Gaucher's disease.Lab Invest. 1988 Jan;58(1):5-25. Lab Invest. 1988. PMID: 3275832 Review. No abstract available.
Cited by
-
Erythrocyte-mediated delivery of recombinant enzymes.J Inherit Metab Dis. 2016 Jul;39(4):519-30. doi: 10.1007/s10545-016-9926-0. Epub 2016 Mar 30. J Inherit Metab Dis. 2016. PMID: 27026098 Review.
-
Imiglucerase in the treatment of Gaucher disease: a history and perspective.Drug Des Devel Ther. 2012;6:81-106. doi: 10.2147/DDDT.S14395. Epub 2012 Apr 18. Drug Des Devel Ther. 2012. PMID: 22563238 Free PMC article. Review.
-
Particulate systems for targeting of macrophages: basic and therapeutic concepts.J Innate Immun. 2012;4(5-6):509-28. doi: 10.1159/000339153. Epub 2012 Jun 19. J Innate Immun. 2012. PMID: 22722900 Free PMC article. Review.
-
Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.Adv Drug Deliv Rev. 2021 Nov;178:113992. doi: 10.1016/j.addr.2021.113992. Epub 2021 Sep 29. Adv Drug Deliv Rev. 2021. PMID: 34597748 Free PMC article. Review.
-
Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.Ther Deliv. 2015 Jul;6(7):795-826. doi: 10.4155/tde.15.34. Ther Deliv. 2015. PMID: 26228773 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical